Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation
Saved in:
Main Authors: | Saori Takamura, Tomoo Fukuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical Journals Sweden
2025-07-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: | https://medicaljournalssweden.se/actadv/article/view/43999 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study
by: Lingyu Hu, et al.
Published: (2023-07-01) -
Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid
by: Na Zhang, et al.
Published: (2025-06-01) -
Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid
by: Na Zhang, et al.
Published: (2025-07-01) -
Home‐based collaborative management of bullous pemphigoid with delayed seropositive conversion of anti‐BP180‐NC16a antibody
by: Hiromitsu Yamashita, et al.
Published: (2025-07-01) -
Bullous pemphigoid of Lever against the background of combined somatic pathology
by: E. N. Efanova, et al.
Published: (2021-06-01)